NCT04154956 2025-08-05
CARMEN-LC03
Sanofi
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT04923945 2025-03-07
Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients
Hutchmed
Phase 3 Completed
NCT05800223 2023-04-05
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
Shanghai Cancer Hospital, China
Phase 3 Recruiting
NCT01966003 2017-10-19
Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer
Amgen
Phase 3 Completed